Annual Total Debt
$274.00 K
-$207.00 K-43.04%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual total debt is $274.00 thousand, with the most recent change of -$207.00 thousand (-43.04%) on December 31, 2023.
- During the last 3 years, SPRY annual total debt has fallen by -$9.74 million (-97.26%).
- SPRY annual total debt is now -97.26% below its all-time high of $10.02 million, reached on December 1, 2020.
Performance
SPRY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$102.00 K
-$58.00 K-36.25%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly total debt is $102.00 thousand, with the most recent change of -$58.00 thousand (-36.25%) on September 30, 2024.
- Over the past year, SPRY quarterly total debt has dropped by -$58.00 thousand (-36.25%).
- SPRY quarterly total debt is now -98.87% below its all-time high of $9.03 million, reached on December 1, 2021.
Performance
SPRY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SPRY Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.0% | -36.3% |
| 3 y3 years | -97.3% | -36.3% |
| 5 y5 years | -97.3% | -36.3% |
SPRY Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.0% | at low | -98.9% | -100.0% |
| 5 y | 5-year | -97.3% | at low | -98.9% | -100.0% |
| alltime | all time | -97.3% | at low | -98.9% | -100.0% |
ARS Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $102.00 K(-36.3%) |
| Jun 2024 | - | $160.00 K(-26.3%) |
| Mar 2024 | - | $217.00 K(-20.8%) |
| Dec 2023 | $274.00 K(-43.0%) | $274.00 K(-16.2%) |
| Sep 2023 | - | $327.00 K(-13.7%) |
| Jun 2023 | - | $379.00 K(-12.1%) |
| Mar 2023 | - | $431.00 K(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $481.00 K(-94.7%) | $481.00 K(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $7.25 M(>+9900.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $9.03 M(-9.8%) | - |
| Dec 2021 | - | $9.03 M |
| Dec 2020 | $10.02 M | - |
FAQ
- What is ARS Pharmaceuticals annual total debt?
- What is the all time high annual total debt for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual total debt year-on-year change?
- What is ARS Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly total debt year-on-year change?
What is ARS Pharmaceuticals annual total debt?
The current annual total debt of SPRY is $274.00 K
What is the all time high annual total debt for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual total debt is $10.02 M
What is ARS Pharmaceuticals annual total debt year-on-year change?
Over the past year, SPRY annual total debt has changed by -$207.00 K (-43.04%)
What is ARS Pharmaceuticals quarterly total debt?
The current quarterly total debt of SPRY is $102.00 K
What is the all time high quarterly total debt for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly total debt is $9.03 M
What is ARS Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, SPRY quarterly total debt has changed by -$58.00 K (-36.25%)